# One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.

> **NCT05069714** · PHASE3 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 184 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Autoimmune Diseases
- Influenza
- Vaccine Reaction

## Interventions

- **DRUG:** MTX-hold

## Key facts

- **NCT ID:** NCT05069714
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2022-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05069714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05069714, "One or Two Week Methotrexate Discontinuation on Efficacy of Influenza Vaccination in Rheumatoid Arthritis.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05069714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*